Phase II study of salvage HDR brachytherapy combined with external beam radiotherapy for isolated prostate bed relapse after radical prostatectomy: preliminary clinical results
Combined salvage HDR brachytherapy followed by EBRT for PSMA-detected IPBR is feasible, achieves excellent early biochemical control, and preserves quality of life with favorable toxicity. The trial was closed without completing the target size due to slow accrual although these results warrant confirmation in larger multicenter trials.
Authors
- Adriana Ayestarán (ORCID: https://orcid.org/0000-0003-0889-0522)
- Marcos Torres
- Rafael Martínez‐Monge (ORCID: https://orcid.org/0000-0002-6285-4816)
- Javier Ancizu‐Marckert
- Alberto Benito (ORCID: https://orcid.org/0000-0002-1527-0092)
- M. Teresa Fontanilla Echeveste
- Macarena Rodríguez‐Fraile (ORCID: https://orcid.org/0000-0002-9069-7918)
- Benigno Barbés (ORCID: https://orcid.org/0000-0002-2005-2524)
- Luis Labairu Huerta (ORCID: https://orcid.org/0000-0002-3882-4203)
- Sara Fadrique
- Luis Fuertes Vallés
- Marian Aristu Mendioroz
Institutions
- Clinica Universidad de Navarra (ES)
Publication Details
- Journal
- Radiotherapy and Oncology
- Published
- 2025-10-17
- DOI
- https://doi.org/10.1016/j.radonc.2025.111215
- Citations
- 1
- Primary Topic
- Prostate Cancer Diagnosis and Treatment
- Type
- article
- Field-Weighted Citation Impact
- 1.52